This is an investigation of possible relationships between daily physical activity (PA) and different measurements of fatigue in cancer survivors participating…

Cancer Remission

~Estimated

~$10 – $750

University of Colorado, DenverNCT05073848

Phase 1

Phase I, First in Human, Open Label Study to Evaluate Safety and Tolerability of TRX103 Cells in Subjects With Hematological Malignancies Undergoing HLA-mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT)

The purpose of this Phase 1, first in human open-label study is to assess the safety and tolerability of TRX-103 in patients with hematological malignancies un…

Hematologic MalignancyGvHDGVHD,Acute+8 more

~Estimated

~$10 – $8,750

Tr1X, Inc.NCT06462365